Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Risk factors involved in orofacial cleft predisposition - review.

Kawalec A, Nelke K, Pawlas K, Gerber H.

Open Med (Wars). 2015 Feb 5;10(1):163-175. doi: 10.1515/med-2015-0027. eCollection 2015. Review.

2.

Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies.

Petersen I, Collings SL, McCrea RL, Nazareth I, Osborn DP, Cowen PJ, Sammon CJ.

Clin Epidemiol. 2017 Feb 16;9:95-103. doi: 10.2147/CLEP.S118336. eCollection 2017.

3.

Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Craig JJ.

Obstet Med. 2012 Mar;5(1):6-13. doi: 10.1258/om.2011.110071. Epub 2012 Feb 20. Review.

4.

The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review.

de Jong J, Garne E, de Jong-van den Berg LT, Wang H.

Drugs Real World Outcomes. 2016 May 24;3(2):131-143. eCollection 2016 Jun. Review.

5.

Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies.

Dolk H, Wang H, Loane M, Morris J, Garne E, Addor MC, Arriola L, Bakker M, Barisic I, Doray B, Gatt M, Kallen K, Khoshnood B, Klungsoyr K, Lahesmaa-Korpinen AM, Latos-Bielenska A, Mejnartowicz JP, Nelen V, Neville A, O'Mahony M, Pierini A, Rißmann A, Tucker D, Wellesley D, Wiesel A, de Jong-van den Berg LT.

Neurology. 2016 May 3;86(18):1716-25. doi: 10.1212/WNL.0000000000002540. Epub 2016 Apr 6.

6.

Mood stabilizers in pregnancy and lactation.

Grover S, Avasthi A.

Indian J Psychiatry. 2015 Jul;57(Suppl 2):S308-23. doi: 10.4103/0019-5545.161498. Review.

7.

Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.

Epstein RA, Moore KM, Bobo WV.

Drug Healthc Patient Saf. 2014 Dec 24;7:7-29. doi: 10.2147/DHPS.S50556. eCollection 2015. Review.

8.

Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.

Rasmussen SA, Hernandez-Diaz S, Abdul-Rahman OA, Sahin L, Petrie CR, Keppler-Noreuil KM, Frey SE, Mason RM, Nesin M, Carey JC.

Clin Infect Dis. 2014 Dec 15;59 Suppl 7:S428-36. doi: 10.1093/cid/ciu738.

9.

Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry.

Sinclair S, Cunnington M, Messenheimer J, Weil J, Cragan J, Lowensohn R, Yerby M, Tennis P.

Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):779-86. doi: 10.1002/pds.3659. Epub 2014 Jun 27. Review.

10.

Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis.

Tricco AC, Cogo E, Angeliki VA, Soobiah C, Hutton B, Hemmelgarn BR, Moher D, Finkelstein Y, Straus SE.

Syst Rev. 2014 Jun 25;3:68. doi: 10.1186/2046-4053-3-68. Review.

11.

Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsants.

Hernández-Díaz S, Levin M.

Reprod Toxicol. 2014 Aug;47:111-4. doi: 10.1016/j.reprotox.2014.04.008. Epub 2014 May 6.

12.

The use of central nervous system active drugs during pregnancy.

Källén B, Borg N, Reis M.

Pharmaceuticals (Basel). 2013 Oct 10;6(10):1221-86. doi: 10.3390/ph6101221.

13.

Clozapine-related EEG changes and seizures: dose and plasma-level relationships.

Varma S, Bishara D, Besag FM, Taylor D.

Ther Adv Psychopharmacol. 2011 Apr;1(2):47-66. doi: 10.1177/2045125311405566.

14.

Epilepsy drugs and effects on fetal development: Potential mechanisms.

Etemad L, Moshiri M, Moallem SA.

J Res Med Sci. 2012 Sep;17(9):876-81.

15.

Are newer antiepileptic drugs associated with improved safety in pregnancy compared to older antiepileptic drugs?

Pack AM.

Epilepsy Curr. 2013 Jan;13(1):15-6. doi: 10.5698/1535-7511-13.1.15. No abstract available.

16.

Antiepileptic drugs during pregnancy in primary care: a UK population based study.

Man SL, Petersen I, Thompson M, Nazareth I.

PLoS One. 2012;7(12):e52339. doi: 10.1371/journal.pone.0052339. Epub 2012 Dec 18.

17.

Women and epilepsy.

O'Connor SE, Zupanc ML.

J Pediatr Pharmacol Ther. 2009 Oct;14(4):212-20. doi: 10.5863/1551-6776-14.4.212.

18.

Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings.

Mehta U, Clerk C, Allen E, Yore M, Sevene E, Singlovic J, Petzold M, Mangiaterra V, Elefant E, Sullivan FM, Holmes LB, Gomes M.

BMC Pregnancy Childbirth. 2012 Sep 3;12:89. doi: 10.1186/1471-2393-12-89.

19.

Use of topiramate in pregnancy and risk of oral clefts.

Margulis AV, Mitchell AA, Gilboa SM, Werler MM, Mittleman MA, Glynn RJ, Hernandez-Diaz S; National Birth Defects Prevention Study.

Am J Obstet Gynecol. 2012 Nov;207(5):405.e1-7. doi: 10.1016/j.ajog.2012.07.008. Epub 2012 Jul 16.

20.

Antiepileptic drugs and pregnancy outcomes.

Wlodarczyk BJ, Palacios AM, George TM, Finnell RH.

Am J Med Genet A. 2012 Aug;158A(8):2071-90. doi: 10.1002/ajmg.a.35438. Epub 2012 Jun 18. Review.

Supplemental Content

Support Center